Literature DB >> 8899854

Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex.

J C Fréville1, G Dollo, P Le Corre, F Chevanne, R Le Verge.   

Abstract

PURPOSE: To investigate the influence of complexation between bupivacaine and hydroxypropyl-beta-cyclodextrin (HP-beta-CD) on the systemic absorption and on the pharmacodynamic effect of bupivacaine following epidural administration in a rabbit model.
METHODS: Bupivacaine and bupivacaine-HP-beta-CD complex were administered according to a randomized and cross-over design in six rabbits chronically instrumented with an epidural catheter. The plasma concentrations of bupivacaine and the duration and intensity of the motor blockade were evaluated.
RESULTS: Complexation with HP-beta-CD led to a decrease in the maximum plasma concentration of bupivacaine. Individual absorption kinetics evaluated by Loo-Riegelman absorption analysis indicated that systemic absorption resulted from two parallel first-order processes. Only the faster absorption phase was slowed by complexation with HP-beta-CD. The duration of the motor blockade was increased almost twice but the intensity was not modified.
CONCLUSIONS: Complexation with HP-beta-CD could be a promising drug delivery system to improve the therapeutic index of bupivacaine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899854     DOI: 10.1023/a:1016000217550

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.

Authors:  J Jang; T L Yaksh; H F Hill
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

2.  Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine.

Authors:  T Mashimo; I Uchida; M Pak; A Shibata; S Nishimura; Y Inagaki; I Yoshiya
Journal:  Anesth Analg       Date:  1992-06       Impact factor: 5.108

3.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

4.  High-performance liquid chromatographic determination of bupivacaine in plasma samples for biopharmaceutical studies and application to seven other local anaesthetics.

Authors:  P Le Guévello; P Le Corre; F Chevanne; R Le Verge
Journal:  J Chromatogr       Date:  1993-12-22

5.  Effect of (hydroxypropyl)-beta-cyclodextrin on flux of morphine, fentanyl, sufentanil, and alfentanil through the spinal meninges of monkey.

Authors:  C M Bernards
Journal:  J Pharm Sci       Date:  1994-05       Impact factor: 3.534

Review 6.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

7.  Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres.

Authors:  P Le Corre; J P Estèbe; F Chevanne; Y Mallédant; R Le Verge
Journal:  J Pharm Sci       Date:  1995-01       Impact factor: 3.534

8.  Prolongation of lidocaine-induced epidural anesthesia by medium molecular weight hyaluronic acid formulations: pharmacodynamic and pharmacokinetic studies in the rabbit.

Authors:  M M Doherty; P J Hughes; N V Korszniak; W N Charman
Journal:  Anesth Analg       Date:  1995-04       Impact factor: 5.108

9.  Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives.

Authors:  R A Rajewski; G Traiger; J Bresnahan; P Jaberaboansari; V J Stella; D O Thompson
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

10.  Spinal anesthesia: significant prolongation of the pharmacologic effect of tetracaine with lipid solution of the agent.

Authors:  L Langerman; E Golomb; S Benita
Journal:  Anesthesiology       Date:  1991-01       Impact factor: 7.892

View more
  1 in total

1.  Antinociceptive effects of bupivacaine and its sulfobutylether-β-cyclodextrin inclusion complex in orofacial pain.

Authors:  Juliana Souza de Freitas Domingues; Silmara Martins Dias Dos Santos; Julia das Neves Rodrigues Ferreira; Bianca Miguel Monti; Darciane Favero Baggio; Wagner Hummig; Erika Ivanna Araya; Eneida de Paula; Juliana Geremias Chichorro; Luiz Eduardo Nunes Ferreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-08-01       Impact factor: 3.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.